

<!doctype html>
<html lang="en">
  <head>
    <!-- Required meta tags -->
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">

    <!-- Bootstrap CSS -->
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.1.1/dist/css/bootstrap.min.css" rel="stylesheet" integrity="sha384-F3w7mX95PdgyTmZZMECAngseQB83DfGTowi0iMjiWaeVhAn4FJkqJByhZMI3AhiU" crossorigin="anonymous">

    <link rel="stylesheet" href="style.css">

    <title>Pymauceuticals Analysis</title>
  </head>
  <body>

    

    <div class="container">
        <div class="jumbotron">
          <h1 class="display-4">Pymauceuticals Analysis</h1>
          <p class="lead">Pymaceuticals Inc., a burgeoning pharmaceutical company based out of San Diego, specializes in anti-cancer pharmaceuticals. In its most recent efforts, it began screening for potential treatments for squamous cell carcinoma (SCC), a commonly occurring form of skin cancer.</p>
          <hr class="my-4">
          <p>In this study, 249 mice identified with SCC tumor growth were treated through a variety of drug regimens. Over the course of 45 days, tumor development was observed and measured. The purpose of this study was to compare the performance of Pymaceuticalsâ€™ drug of interest, Capomulin, versus the other treatment regimens. Below are the results from this study. </p>
          <a class="btn btn-primary btn-lg" href="#" role="button">Learn more</a>
        </div>
      </div>


    <!-- Option 1: Bootstrap Bundle with Popper -->
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.1.1/dist/js/bootstrap.bundle.min.js" integrity="sha384-/bQdsTh/da6pkI1MST/rWKFNjaCP5gBSY4sEBT38Q/9RBh9AH40zEOg7Hlq2THRZ" crossorigin="anonymous"></script>


  </body>
</html>